Leprosy natural history, complications and prognosis

Jump to navigation Jump to search

Leprosy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leprosy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leprosy natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leprosy natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leprosy natural history, complications and prognosis

CDC on Leprosy natural history, complications and prognosis

Leprosy natural history, complications and prognosis in the news

Blogs on Leprosy natural history, complications and prognosis

Directions to Hospitals Treating Leprosy

Risk calculators and risk factors for Leprosy natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Leprosy may lead to severe complications if not diagnosed and treated early, which will affect the prognosis.

Natural History

Leprosy, or Hansen's disease, is caused by Mycobacterium leprae, a gram-positive obligate intracellular, acid-fast bacillus.

Although the mechanism of transmission is not well understood, it is though that the respiratory mucosa and skin play an important role in the transmission of the disease.

The symptoms of the disease might not occur until 12 years after the exposure to the bacteria. Common initial symptoms may include loss of sensation of a hipopigmented skin patch and a thickened peripheral nerve concomitantly with weakness or loss of sensation of the area

Without treatment symptoms will develop and include skin ulcers, eye problems, nasal congestion, epistaxis, muscle contractures and eventually complicate into paralysis and blindness.

Complications

One to two million persons worldwide are permanently disabled as a result of leprosy.[1] The number and degree of complications will depend on how early the condition is diagnosed and treatment with multidrug therapy is started. A late diagnosis will increase the number and severity of the complications. These may include:[2][3]

  • Lucio phenomenon - rare but potentially fatal complication, occurring predominantly in untreated lepromatous patients, as an acute necrotizing vasculopathy. It is common to observe painful irregular patches that usually become pruritic, developing bullae. This phenomenon has been noted to occur predominantly in descendants from mexican populations.[4][5]

Prognosis

Leprosy is a curable disease when adequately treated. With early diagnosis and treatment, the damages inflicted in patients by the disease may be reduced. Therefore, early recognition and prompt treatment are essential to improve the prognosis of patients, increasing the chances of a normal lifestyle. To improve the chances of a better prognosis, physicians, particularly of endemic areas, must be aware of the early signs and symptoms of the disease and the population must be educated to avoid infection and search medical attention when such symptoms appear, thereby minimizing complications.

References

  1. Walker, Stephen L.; Lockwood, Dina N.J. (2007). "Leprosy". Clinics in Dermatology. 25 (2): 165–172. doi:10.1016/j.clindermatol.2006.05.012. ISSN 0738-081X.
  2. Daniel E, Ffytche TJ, Kempen JH, Rao PS, Diener-West M, Courtright P (2006). "Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy". Br J Ophthalmol. 90 (8): 949–54. doi:10.1136/bjo.2006.094870. PMC 1857220. PMID 16707521.
  3. "P Hansen's Disease (Leprosy)". line feed character in |title= at position 2 (help)
  4. Rea, Thomas H. (1977). "Current Concepts in the Immunology of Leprosy". Archives of Dermatology. 113 (3): 345. doi:10.1001/archderm.1977.01640030091017. ISSN 0003-987X.
  5. Sehgal VN, Srivastava G, Sharma VK (1987). "Contemplative immune mechanism of Lucio phenomenon and its global status". J Dermatol. 14 (6): 580–5. PMID 3329658.


Template:WikiDoc Sources